M. Zastrozhin

Influence of ABCB1 3435C>T polymorphism on methotrexate safety in patients with psoriasis

A. Kubanov, Z. Sozaeva, D. Sychev, 2023, Vestnik dermatologii i venerologii.

Effects of CYP2C19*2 polymorphisms on the efficacy and safety of phenazepam in patients with anxiety disorder and comorbid alcohol use disorder.

L. M. Savchenko, E. Grishina, K. Ryzhikova, 2020, Pharmacogenomics.

The effect of CYP2D6 and CYP2C9 gene polymorphisms on the efficacy and safety of the combination of tramadol and ketorolac used for postoperative pain management in patients after video laparoscopic cholecystectomy

D. Sychev, Z. Sozaeva, L. Kerimova, 2021, Drug metabolism and personalized therapy.

The effect of CYP2D6 and CYP2C9 gene polymorphisms on the efficacy and safety of the combination of tramadol and ketorolac used for postoperative pain management in patients after video laparoscopic cholecystectomy

D. Sychev, Z. Sozaeva, L. Kerimova, 2021, Drug metabolism and personalized therapy.

Personalized approach to the administration of haloperidol in patients with acute alcoholic hallucinatie (literature review)

M. Zastrozhin, Aleksandra Aleksandrovna Parkhomenko, V. Skryabin, 2021, Vestnik nevrologii, psihiatrii i nejrohirurgii (Bulletin of Neurology, Psychiatry and Neurosurgery).

Using a personalized clinical decision support system for bromdihydrochlorphenylbenzodiazepine dosing in patients with anxiety disorders based on the pharmacogenomic markers

E. Grishina, E. Bryun, D. Sychev, 2018, Human psychopharmacology.

CYP3A subfamily activity affects the equilibrium concentration of Phenazepam® in patients with anxiety disorders and comorbid alcohol use disorder.

M. Zastrozhin, E. P. Pankratenko, E. Grishina, 2020, Pharmacogenomics.